BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 17637819)

  • 1. Bim expression is reduced in human cutaneous melanomas.
    Dai DL; Wang Y; Liu M; Martinka M; Li G
    J Invest Dermatol; 2008 Feb; 128(2):403-7. PubMed ID: 17637819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDH22 expression is reduced in metastatic melanoma.
    Piche B; Khosravi S; Martinka M; Ho V; Li G
    Am J Cancer Res; 2011; 1(2):233-239. PubMed ID: 21969168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Box C/D snoRNA SNORD89 influences the occurrence and development of endometrial cancer through 2'-O-methylation modification of Bim.
    Bao HJ; Chen X; Liu X; Wu W; Li QH; Xian JY; Zhao Y; Chen S
    Cell Death Discov; 2022 Jul; 8(1):309. PubMed ID: 35790714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound Kushen Injection Protects Skin From Radiation Injury
    Zheng J; Li G; Wang J; Wang S; Tang Q; Sheng H; Wu W; Wang S
    Front Pharmacol; 2021; 12():753068. PubMed ID: 34955827
    [No Abstract]   [Full Text] [Related]  

  • 5. Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma.
    Wang JD; Katz SG; Morgan EA; Yang DT; Pan X; Xu ML
    Hum Pathol; 2019 Nov; 93():54-64. PubMed ID: 31425695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the
    Atsumi J; Shimizu K; Ohtaki Y; Kaira K; Kakegawa S; Nagashima T; Enokida Y; Nakazawa S; Obayashi K; Takase Y; Kawashima O; Kamiyoshihara M; Sugano M; Ibe T; Igai H; Takeyoshi I
    J Glob Oncol; 2016 Feb; 2(1):15-25. PubMed ID: 28717678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deubiquitinase Usp27x stabilizes the BH3-only protein Bim and enhances apoptosis.
    Weber A; Heinlein M; Dengjel J; Alber C; Singh PK; Häcker G
    EMBO Rep; 2016 May; 17(5):724-38. PubMed ID: 27013495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Bim in Health and Disease.
    Sionov RV; Vlahopoulos SA; Granot Z
    Oncotarget; 2015 Sep; 6(27):23058-134. PubMed ID: 26405162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell death.
    Kafara P; Icard P; Guillamin M; Schwartz L; Lincet H
    J Ovarian Res; 2015 Jun; 8():36. PubMed ID: 26063499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells.
    Liu YL; Lai F; Wilmott JS; Yan XG; Liu XY; Luan Q; Guo ST; Jiang CC; Tseng HY; Scolyer RA; Jin L; Zhang XD
    Oncotarget; 2014 Nov; 5(22):11237-51. PubMed ID: 25365078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2.
    Merino D; Best SA; Asselin-Labat ML; Vaillant F; Pal B; Dickins RA; Anderson RL; Strasser A; Bouillet P; Lindeman GJ; Visvader JE
    Oncogene; 2015 Jul; 34(30):3926-34. PubMed ID: 25263453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mantle cell lymphoma in cyclin D1 transgenic mice with Bim-deficient B cells.
    Katz SG; Labelle JL; Meng H; Valeriano RP; Fisher JK; Sun H; Rodig SJ; Kleinstein SH; Walensky LD
    Blood; 2014 Feb; 123(6):884-93. PubMed ID: 24352880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme.
    Cartron PF; Loussouarn D; Campone M; Martin SA; Vallette FM
    Cell Death Dis; 2012 Nov; 3(11):e421. PubMed ID: 23152057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.
    Engesæter B; Engebraaten O; Flørenes VA; Mælandsmo GM
    PLoS One; 2012; 7(9):e45492. PubMed ID: 23029050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel multiple markers to distinguish melanoma from dysplastic nevi.
    Zhang G; Li G
    PLoS One; 2012; 7(9):e45037. PubMed ID: 23028750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient outcome prediction using multiple biomarkers in human melanoma: A clinicopathological study of 118 cases.
    Li J; Zhang Z; Li G
    Exp Ther Med; 2011 Jan; 2(1):131-135. PubMed ID: 22977480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,3-Bis(3,5-dichlorophenyl) urea compound 'COH-SR4' inhibits proliferation and activates apoptosis in melanoma.
    Singhal SS; Figarola J; Singhal J; Leake K; Nagaprashantha L; Lincoln C; Gabriel Gugiu B; Horne D; Jove R; Awasthi S; Rahbar S
    Biochem Pharmacol; 2012 Dec; 84(11):1419-27. PubMed ID: 22959823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Born to be alive: a role for the BCL-2 family in melanoma tumor cell survival, apoptosis, and treatment.
    Anvekar RA; Asciolla JJ; Missert DJ; Chipuk JE
    Front Oncol; 2011 Oct; 1(34):. PubMed ID: 22268005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS.
    Jiang CC; Lai F; Tay KH; Croft A; Rizos H; Becker TM; Yang F; Liu H; Thorne RF; Hersey P; Zhang XD
    Cell Death Dis; 2010 Sep; 1(9):e69. PubMed ID: 21364673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim.
    Moujalled D; Weston R; Anderton H; Ninnis R; Goel P; Coley A; Huang DC; Wu L; Strasser A; Puthalakath H
    EMBO Rep; 2011 Jan; 12(1):77-83. PubMed ID: 21151042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.